Kenna R. Mills Shaw, Ph.D.
Cancer Genomics Laboratory
Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment Information
Kenna R. Mills Shaw, Ph.D., is passionate about doing the right thing for the right reasons for all of our patients. But she's also a realist that's trying to bring some reality to the hype surrounding precision medicine, in hopes of delivering on the promise of research-driven care for patients here and elsewhere.
I had 17 days from the time my father was diagnosed with kidney
cancer to the day I held him as he died. Seventeen days. By the time
we knew, the cancer had metastasized throughout his body. My dad was
otherwise healthy; he ate well, exercised and hadn't smoked in more
than 25 years. But I knew that cancer is not all that selective.
Instead of asking "why him?" I asked, "Why not? Why not
me? Why not my children?" And so I work with the hope of giving
people more days, years, memories and quality of life.
A large piece of what we do is share our data and knowledge. I'm excited to be able to help lower barriers to data sharing here at our own institution and minimize risks, both perceived and real. I want our work to help show that data sharing enables us to accelerate discoveries.
I want to deliver on what we promise. I want to make sure our
world-class scientists and clinicians have what they need to deliver
change in this field.
Cancer is a complex network. No one data type or no one cancer type
will give us what we need to move novel therapies forward. The Moon
Shots Program™ helps us develop experiments that dissect cancer’s
complexities through multiple platforms and scientific approaches.
This “multi-disciplinary” approach that makes us excel at cancer care
is also what's driving our research paradigm.
Our group, the Cancer Genomics Laboratory Moon Shot™ research
platform, aims to streamline the delivery of genomic data (the
sequence of the DNA and RNA in patient tumor samples) to our
investigators. We aim to provide consistent, high-quality data and
analysis in an environment of transparency. Our service-oriented
approach means that we're constantly striving to report our progress
and constantly delivering to our customers.
I like to believe I set the expectation of honest, straightforward,
action-oriented leadership to my team, my peers and other colleagues
at our institution.